These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 7170258)

  • 21. Octabromodiphenyl ether - porphyrogenicity after repeated administration to rats.
    Bruchajzer E; Frydrych B; Szymańska JA
    Int J Occup Med Environ Health; 2012 Sep; 25(4):392-403. PubMed ID: 23086635
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Porphyrins in liver tissue, bile and urine of patients with symptomatic hepatic porphyria (SHP) (proceedings)].
    Kaláb M; Jirsa M; Kordac V; Soldátová H; Papezová R
    Cesk Gastroenterol Vyz; 1978 Dec; 32(8):519-20. PubMed ID: 737775
    [No Abstract]   [Full Text] [Related]  

  • 23. [Concentration of dihydroepiandrosterone, dihydroepiandrosterone sulphate and testosterone during premature menopause in women chronically exposed to carbon disulfide].
    Stanosz S; Kuligowski D; Pieleszek A
    Med Pr; 1995; 46(4):337-40. PubMed ID: 7476147
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Oxidative phosphorylation in experimental hepatic porphyria].
    Panfil B; Dancewicz A
    Acta Physiol Pol; 1971; 22(6):846-8. PubMed ID: 5152824
    [No Abstract]   [Full Text] [Related]  

  • 25. The hepatic porphyrias: pathogenesis, manifestations, and management.
    Bloomer JR
    Gastroenterology; 1976 Oct; 71(4):689-701. PubMed ID: 955357
    [No Abstract]   [Full Text] [Related]  

  • 26. The porphyrias: a review.
    Elder GH; Gray CH; Nicholson DC
    J Clin Pathol; 1972 Dec; 25(12):1013-33. PubMed ID: 4570617
    [No Abstract]   [Full Text] [Related]  

  • 27. Porphyrins in urine as an indication of exposure to chlorinated hydrocarbons.
    Strik JJ
    Ann N Y Acad Sci; 1987; 514():219-21. PubMed ID: 3442385
    [No Abstract]   [Full Text] [Related]  

  • 28. [Modification of porphyrin-metabolism through environmental factors].
    Simon N; Siklósi C
    Berufsdermatosen; 1974; 22(6):237-59. PubMed ID: 4464832
    [No Abstract]   [Full Text] [Related]  

  • 29. [Hepatic tolerance to ultracaine. Effect on porphyria].
    Schutz E; Fuchs H
    Inf Dent; 1986 Mar; 68(12):1031-8. PubMed ID: 3462132
    [No Abstract]   [Full Text] [Related]  

  • 30. Carbon disulfide and the central nervous system: a 15-year neurobehavioral surveillance of an exposed population.
    Cassitto MG; Camerino D; Imbriani M; Contardi T; Masera L; Gilioli R
    Environ Res; 1993 Nov; 63(2):252-63. PubMed ID: 8243419
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Experimental hepatic porphyria: studies with steroids of physiological origin in man.
    Kappas A; Granick S
    Ann N Y Acad Sci; 1968 Jul; 151(2):842-9. PubMed ID: 5263692
    [No Abstract]   [Full Text] [Related]  

  • 32. The heme biosynthesis pathway and clinical manifestations of abnormal function.
    Phillips JD; Kushner JP
    Curr Protoc Toxicol; 2001 May; Chapter 8():Unit 8.1. PubMed ID: 20954154
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The biochemical basis of the acute porphyrias.
    McColl KE; Goldberg A
    Biochem Soc Trans; 1983 Dec; 11(6):631-2. PubMed ID: 6336314
    [No Abstract]   [Full Text] [Related]  

  • 34. [Hepatic porphyrias].
    Crispin M; Szeinberg A
    Harefuah; 1972 Feb; 82(3):137-9. PubMed ID: 4565661
    [No Abstract]   [Full Text] [Related]  

  • 35. Toxicological aspects of liver heme biosynthesis.
    De Matteis F
    Semin Hematol; 1988 Oct; 25(4):321-9. PubMed ID: 3064313
    [No Abstract]   [Full Text] [Related]  

  • 36. Lead poisoning as a disorder of heme synthesis.
    Goldberg A
    Semin Hematol; 1968 Oct; 5(4):424-33. PubMed ID: 5742911
    [No Abstract]   [Full Text] [Related]  

  • 37. Experimental porphyria. II. Drug-induced porphyrin biosynthesis.
    Creighton JM; Racz WJ; Tyrrell DL; Schneck DW; Marks GS
    S Afr Med J; 1971 Sep; ():79-81. PubMed ID: 5150298
    [No Abstract]   [Full Text] [Related]  

  • 38. [Microluminescence, ultrastructure, porphyrin metabolism in liver diseases].
    Róth I; Várkonyi S; Goreczky L; Breckner M; Szücs O; Balázs M
    Z Gesamte Inn Med; 1971 May; 26(10):323-7. PubMed ID: 5131400
    [No Abstract]   [Full Text] [Related]  

  • 39. [Neurological aspects of exposure to toxic agents in industry (author's transl)].
    Foa V; Gilioli R
    Riv Patol Nerv Ment; 1974 Dec; 95(6):795-836. PubMed ID: 4470280
    [No Abstract]   [Full Text] [Related]  

  • 40. [Disturbances of metabolism in experimental porphyrias].
    Panfil B
    Postepy Hig Med Dosw; 1969; 23(3):275-91. PubMed ID: 4896416
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.